Key statistics
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | -- |
| Low | -- |
| Bid | -- |
| Offer | -- |
| Previous close | -- |
| Average volume | -- |
|---|---|
| Shares outstanding | 29.02m |
| Free float | 27.66m |
| P/E (TTM) | -- |
| Market cap | 401.33m USD |
| EPS (TTM) | -3.84 USD |
Data delayed at least 15 minutes.
More ▼
Press releases
- Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025
- Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
- Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2025
More ▼
